Yonghong Li
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 14, 2026
Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer.
Journal: Science advances
Published: January 16, 2026
A phase II study evaluating pharmacokinetics and dosimetry of 177Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer.
Journal: EJNMMI research
Published: June 19, 2025
Risk of seizure in patients with prostate cancer treated with enzalutamide in China: a noninterventional study.
Journal: Therapeutic advances in drug safety
Published: March 25, 2025
Osteosclerotic changes on computed tomography predict disease progression and poor survival in prostate cancer with osteoblastic metastases.
Journal: International journal of surgery (London, England)
Published: March 23, 2025
Predicting pathogenic DNA damage repair gene mutations in prostate cancer patients: a multi-center magnetic resonance imaging radiomics study.
Journal: Quantitative imaging in medicine and surgery
Published: December 01, 2024
Clinical characteristics and prognostic factors of low metastatic burden prostate cancer with non-regional lymph node metastases: role of cytoreductive radiotherapy?
Journal: Translational andrology and urology
Published: September 13, 2024
The prognostic value of the 8th American Joint Committee on cancer anatomic and prognostic stage groups for penile cancer: A multicenter collaboration study.
Journal: Asian journal of urology
Published: April 09, 2024
Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.
Journal: Clinical and translational medicine
Published: June 10, 2023
SAVE Testis-sparing score: a multicenter retrospective study of a novel predictive tool for quantifying testicular tumors.
Journal: International journal of surgery (London, England)
Published: June 01, 2023
Development and internal validation of a novel nomogram for predicting lymph node invasion for prostate cancer patients undergoing extended pelvic lymph node dissection.
Journal: Frontiers in oncology
Published: March 14, 2023
Extraperitonealization of the ileal conduit decreases the risk of parastomal hernia: A single-center, randomized clinical trial.
Journal: Cell reports. Medicine
Published: February 27, 2023
Last Updated: 09/26/2026